Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by CleverInvestor2on Jan 11, 2020 4:56pm
90 Views
Post# 30542817

RE:RE:RE:RE:RE:Buy....

RE:RE:RE:RE:RE:Buy....
88guy88 wrote: Its more likely to keep selling down next week as the early investors start to peel off their positions at high valuations.....a bird in the hand theory.......the early news is out and the runup momemtum for now has swung to the downside for now....


We'll have to wait and see. You think it's going down, I think it's going up.
Early investors as in the ones who bought in at $20+ 5 years ago? or are you talking about investors who bought in the last few months below $1? Those are the guys who've been selling the last few days for $1-3. There weren't many shares traded below the $1 mark so there can't be that many sellers.
<< Previous
Bullboard Posts
Next >>